BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/17/2025 7:16:34 AM | Browse: 104 | Download: 341
 |
Received |
|
2025-06-20 01:53 |
 |
Peer-Review Started |
|
2025-06-20 01:53 |
 |
First Decision by Editorial Office Director |
|
2025-07-10 09:06 |
 |
Return for Revision |
|
2025-07-10 09:06 |
 |
Revised |
|
2025-07-20 09:41 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-10-20 02:57 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-10-20 07:17 |
 |
Articles in Press |
|
2025-10-20 07:17 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-12-08 02:26 |
 |
Publish the Manuscript Online |
|
2025-12-17 06:45 |
| ISSN |
2218-5836 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Orthopedics |
| Manuscript Type |
Review |
| Article Title |
Intertwined roles of microRNA-155 and metformin in osteoarthritis: Novel potential diagnostic, prognostic, and therapeutic modulators
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mantana Paisan, Konstantinos I Papadopoulos, Alexandra Papadopoulou, Weerapong Prasongchean and Phanphen Wattanaarsakit |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Konstantinos I Papadopoulos, MD, PhD, Department of R and D, THAI StemLife, 566/3 THAI StemLife Bldg, Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Road, Wangthonglang, Bangkok 10330, Thailand. kostas@thaistemlife.co.th |
| Key Words |
Osteoarthritis; MicroRNA-155; Metformin; Glucagon-like peptide 1; Renin-angiotensin aldosterone system; Cyclooxygenase 2; Adenosine monophosphate-activated protein kinase |
| Core Tip |
In osteoarthritis (OA) and its associated risk factors, elevated microRNA-155 (miR-155) regulates systemic and local joint inflammatory mediators, extracellular matrix degradation, and chondrocyte apoptosis, with context-dependent roles in cartilage repair. MiR-155 also shows promise as a diagnostic and prognostic biomarker. Metformin exerts cartilage-protective effects via adenosine monophosphate-activated protein kinase activation, nuclear factor kappa-B inhibition, and possible modulation of miR-155 expression. Combined miR-155-targeted strategies and metformin in OA could enhance anti-inflammation, cartilage-preservation, and joint regeneration through the development of innovative treatments, including novel articular delivery systems and cell-based therapies. Further research is needed to fully understand the molecular underpinnings of this relationship. |
| Publish Date |
2025-12-17 06:45 |
| Citation |
Paisan M, Papadopoulos KI, Papadopoulou A, Prasongchean W, Wattanaarsakit P. Intertwined roles of microRNA-155 and metformin in osteoarthritis: Novel potential diagnostic, prognostic, and therapeutic modulators. World J Orthop 2025; 16(12): 110992 |
| URL |
https://www.wjgnet.com/2218-5836/full/v16/i12/110992.htm |
| DOI |
https://dx.doi.org/10.5312/wjo.v16.i12.110992 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.